Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment
- PMID: 17243120
- DOI: 10.1002/jcb.21215
Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment
Abstract
Every year about 500,000 people in the United States die as a result of cancer. Among them, 90% exhibit systemic disease with metastasis. Considering this high rate of incidence and mortality, it is critical to understand the mechanisms behind metastasis and identify new targets for therapy. In recent years, two broad mechanisms for metastasis have received significant attention: epithelial-to-mesenchymal transition (EMT) and tumor microenvironment interactions. EMT is believed to be a major mechanism by which cancer cells become migratory and invasive. Various cancer cells--both in vivo and in vitro--demonstrate features of epithelial-to-mesenchymal-like transition. In addition, many steps of metastasis are influenced by host contributions from the tumor microenvironment, which help determine the course and severity of metastasis. Here we evaluate the diverse mechanisms of EMT and tumor microenvironment interactions in the progression of cancer, and construct a rational argument for targeting these pathways to control metastasis.
Similar articles
-
[Epithelial-mesenchymal transition in cancer progression].Postepy Biochem. 2009;55(2):121-8. Postepy Biochem. 2009. PMID: 19824467 Review. Polish.
-
A human three-dimensional cell line model allows the study of dynamic and reversible epithelial-mesenchymal and mesenchymal-epithelial transition that underpins colorectal carcinogenesis.Cells Tissues Organs. 2007;185(1-3):20-8. doi: 10.1159/000101299. Cells Tissues Organs. 2007. PMID: 17587804 Review.
-
Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.Drug Resist Updat. 2008 Aug-Oct;11(4-5):123-51. doi: 10.1016/j.drup.2008.07.001. Epub 2008 Aug 20. Drug Resist Updat. 2008. PMID: 18718806 Review.
-
Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis.Prostate. 2006 Nov 1;66(15):1664-73. doi: 10.1002/pros.20488. Prostate. 2006. PMID: 16902972
-
Mesenchymal to epithelial transition in development and disease.Cells Tissues Organs. 2007;185(1-3):7-19. doi: 10.1159/000101298. Cells Tissues Organs. 2007. PMID: 17587803 Review.
Cited by
-
Cytoarchitecture of Breast Cancer Cells under Diabetic Conditions: Role of Regulatory Kinases-Rho Kinase and Focal Adhesion Kinase.Cancers (Basel). 2024 Sep 15;16(18):3166. doi: 10.3390/cancers16183166. Cancers (Basel). 2024. PMID: 39335137 Free PMC article.
-
Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics.Cancer Metastasis Rev. 2024 Mar;43(1):321-362. doi: 10.1007/s10555-024-10171-0. Epub 2024 Mar 22. Cancer Metastasis Rev. 2024. PMID: 38517618 Review.
-
Expression of overall survival-EMT-immune cell infiltration genes predict the prognosis of glioma.Noncoding RNA Res. 2024 Feb 16;9(2):407-420. doi: 10.1016/j.ncrna.2024.02.003. eCollection 2024 Jun. Noncoding RNA Res. 2024. PMID: 38511063 Free PMC article.
-
Kisspeptin Regulates Cell Invasion and Migration in Endometrial Cancer.J Endocr Soc. 2024 Jan 8;8(3):bvae001. doi: 10.1210/jendso/bvae001. eCollection 2024 Jan 16. J Endocr Soc. 2024. PMID: 38264268 Free PMC article.
-
MALAT-1 Is a Key Regulator of Epithelial-Mesenchymal Transition in Cancer: A Potential Therapeutic Target for Metastasis.Cancers (Basel). 2024 Jan 4;16(1):234. doi: 10.3390/cancers16010234. Cancers (Basel). 2024. PMID: 38201661 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources